论文部分内容阅读
未来2—3年,上海医药会顺应形势做工业整合。整合形势大体是,先商业后工业最后是研发领域5月25日,上海医药在上海浦东香格里拉酒店为庆祝其H股IPO成功发行举办大型答谢会。5天前,上海医药正式登陆香港联交所挂牌交易,其共发行6.64亿新股,发行价为每股23港元(折合人民币约19.21元),以定价区间的中端定
The next 2-3 years, Shanghai Pharmaceutical will adapt to the situation to do industrial consolidation. The general situation of the integration is that after the first commercial post-industrial R & D is the final May 25, Shanghai Pharmaceutical Pudong Shangri-La Hotel in Shanghai to celebrate the successful issuance of its H-share IPO held a large Thanksgiving. 5 days ago, Shanghai Pharmaceutical officially listed on the Hong Kong Stock Exchange, a total of 664 million new shares issued at an issue price of HK $ 23 per share (equivalent to about 19.21 yuan) to the middle of the pricing range